Technology and Oncology Podcast Powered by Carevive

The OCM (Oncology Care Model), launched in 2016, is a payment model designed to help oncology centers transition from the traditional Medicare Fee-for-Service (FFS) payment structure and focus on high-value care.

The EOM (Enhancing Oncology Model) is the next phase model and will replace OCM starting July 1, 2023. EOM will support clinicians caring for patients with seven common cancer types, focusing on health equity and accountable, affordable care.

But what are the revenue-enhancing opportunities in EOM, is it worth the transition from OCM, and what does it actually provide?

On today’s episode of Technology and Oncology Podcast, host Michelle Dawn Mooney speaks with John Elliot, the Vice President of Sales at Carevive to discuss how oncology centers and clinics can transition from OCM to EOM and how they can get assistance for the process.

Michelle Dawn Mooney and John Elliot discussed:

  1. What clients should expect after approval and assistance available to meet the July 1 deadline for launching
  2. Benefits of EOM to oncology patients
  3. Where people can find more information and assistance on the topic

“Looking at oncology, efficiency is key, however, there are limited constrained resources. 24/7 access to electronic records, having a line of communication, capturing symptoms at the right time, access to care with the focus of addressing challenges in the oncology and health care sector which can improve patient outcome and reduce cost – this is what the EOM aims to achieve. The EOM model bridges the gap of communication and ensures members of the care team are aware of what is happening in real-time, which promotes standardization of care,” explained John Elliot.

John Elliot is the Vice President of Sales at Carevive. He received his Bachelor of Arts degree in Advertising from Southern Methodist University and his Master of Business Administration from Washington University in St. Louis-Olin Business School. He has over ten years of experience working with oncology centers.

Follow us on social media for the latest updates in B2B!

Image

Latest

DX
Pursuing the World’s Rarest DX: Vadym Ivliev, UT6UD, and the Story That Led Him to Bouvet
January 16, 2026

For some operators, Bouvet Island represents the ultimate technical challenge. For Vadym Ivliev (UT6UD), it is something more personal—and more mysterious. From his home in Kyiv—far removed from the ice, storms, and isolation of Bouvet—Vadym has long been drawn to the island not only for its legendary radio silence, but for the stories it inspires….

Read More
GameStop
Inside GameStop’s Meteoric Stock Surge: A Former Executive Reflects on Power, Pivots, and the Price of Winning
January 15, 2026

The meme-stock era may feel like old news, but its aftershocks are still reshaping how leaders think about transformation, risk, and reward. In the wake of unprecedented short squeezes, shuttered storefronts, and sudden wealth creation, executives across retail and tech are still asking what actually happened—and why. Few episodes crystallize those questions better than…

Read More
podcast
The DisruptED Journey with Tim Maitland at MarketScale (Episode Three)
January 15, 2026

Storytelling is changing fast, shaped by new platforms, shifting audiences, and a growing demand for authenticity. What started as traditional podcasting has evolved into community-driven ecosystems built on real voices and lived experience. In this landscape, storytelling isn’t just content—it’s a way to build connection, spark engagement, and drive meaningful change. When done well,…

Read More
education
The DisruptED Journey with Tim Maitland at MarketScale (Episode Two)
January 15, 2026

Education is at a crossroads. As AI, online learning, and workforce demands rapidly reshape how people gain skills, long-standing gaps in access and outcomes remain a major concern in Michigan. Recent reporting on the 2025 State of Education and Talent shows Michigan has fallen to its lowest ever ranking in per capita income, underscoring…

Read More